Ascent Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.18M Sell
7,844
-1,007
-11% -$408K 0.12% 162
2025
Q1
$4.4M Buy
8,851
+1,454
+20% +$724K 0.19% 117
2024
Q4
$3.85M Sell
7,397
-699
-9% -$364K 0.29% 88
2024
Q3
$5.01M Sell
8,096
-2,933
-27% -$1.81M 0.38% 57
2024
Q2
$6.1M Buy
11,029
+561
+5% +$310K 0.5% 41
2024
Q1
$6.08M Buy
10,468
+3,484
+50% +$2.02M 0.54% 33
2023
Q4
$3.82M Buy
6,984
+24
+0.3% +$13.1K 0.36% 61
2023
Q3
$3.09M Sell
6,960
-111
-2% -$49.3K 0.34% 69
2023
Q2
$3.93M Sell
7,071
-779
-10% -$433K 0.43% 53
2023
Q1
$4.52M Sell
7,850
-876
-10% -$505K 0.48% 41
2022
Q4
$4.81M Buy
8,726
+530
+6% +$292K 0.57% 33
2022
Q3
$4.21M Buy
8,196
+115
+1% +$59.1K 0.51% 43
2022
Q2
$4.84M Buy
8,081
+431
+6% +$258K 0.58% 32
2022
Q1
$4.52M Sell
7,650
-23
-0.3% -$13.6K 0.53% 42
2021
Q4
$4.45M Buy
+7,673
New +$4.45M 0.57% 36